Thymosin Beta-4 Research
Guarnera 2007 — Thymosin Beta-4 and Venous Ulcers Dose-Escalation Study
Annals of the New York Academy of Sciences·May 1, 2007
G. Guarnera, et al.
Summary
Early human clinical study evaluating safety, tolerability, and wound-healing enhancement of thymosin beta-4 in venous ulcers.
Study Details
Study Design
Double-blind placebo-controlled dose-escalation clinical study
Indication
Venous stasis ulcers
Intervention
Topical thymosin beta-4 vs placebo
Species
Human
Risk of Bias Assessment
Small early-phase wound-healing trial
Tags
SourceClinical TrialThymosin Beta 4Venous UlcerWound HealingHuman
External Links
Metrics
Citations
16Evidence QualityN/A
Last VerifiedMay 9, 2026
Related PeptideThymosin Beta-43 papers